The DOI matches its Crossref record, with a small difference in title or year; 32 of the 33 references it cites were found in a registry or an index.
Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis
Open accessAbstract
Importance: Clinical trials have documented that lowering blood pressure reduces cardiovascular disease and premature deaths. However, the optimal target for reduction of systolic blood pressure (SBP) is uncertain. Objective: To assess the association of mean achieved SBP levels with the risk of cardiovascular disease and all-cause mortality in adults with hypertension treated with antihypertensive therapy. Data Sources: MEDLINE and EMBASE were searched from inception to December 15, 2015, supplemented by manual searches of the bibliographies of retrieved articles. Study Selection: Studies included were clinical trials with random allocation to an antihypertensive medication, control, or treatment target. Studies had to have reported a difference in mean achieved SBP of 5 mm Hg or more between comparison groups. Data Extraction and Synthesis: Data were extracted from each study independently and in duplicate by at least 2 investigators according to a standardized protocol. Network meta-analysis was used to obtain pooled randomized results comparing the association of each 5-mm Hg SBP category with clinical outcomes after adjusting for baseline risk. Main Outcomes and Measures: Cardiovascular disease and all-cause mortality. Results: Forty-two trials, including 144 220 patients, met the eligibility criteria. In general, there were linear associations between mean achieved SBP and risk of cardiovascular disease and mortality, with the lowest risk at 120 to 124 mm Hg. Randomized groups with a mean achieved SBP of 120 to 124 mm Hg had a hazard ratio (HR) for major cardiovascular disease of 0.71 (95% CI, 0.60-0.83) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.58 (95% CI, 0.48-0.72) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.46 (95% CI, 0.34-0.63) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.36 (95% CI, 0.26-0.51) compared with those with a mean achieved SBP of 160 mm Hg or more. Likewise, randomized groups with a mean achieved SBP of 120 to 124 mm Hg had an HR for all-cause mortality of 0.73 (95% CI, 0.58-0.93) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.59 (95% CI, 0.45-0.77) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.51 (95% CI, 0.36-0.71) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.47 (95% CI, 0.32-0.67) compared with those with a mean achieved SBP of 160 mm Hg or more. Conclusions and Relevance: This study suggests that reducing SBP to levels below currently recommended targets significantly reduces the risk of cardiovascular disease and all-cause mortality. These findings support more intensive control of SBP among adults with hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and lowering BP substantially reduces that risk.5–7”
From International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
Self-citationJames, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Research works printed but not linked: 1
- [17]17. Jones DW, Weatherly L, Hall JE. SPRINT: what remains unanswered and where do we go from here? Hypertension. 2016;67(2):261-262.
Cited by
Sorted by citations
Items 701–783 of 783
Zhang, Q., Gan, W., Pei, R., Bao, X., Shimpuku, Y., Chen, S., Song, L., Yin, J., Wang, Y., & Zheng, Y. (2025) · Patient Education and Counseling · doi:10.1016/j.pec.2025.108782
Daiya, V., Archarya, S., Shukla, S., Kumar, S., Manuja, N., Jaiswal, S., Pradeep, U., Hamdulay, K., Kumar, J., & Padwal, A. (2025) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_51_24
Harrison, T. N., Juan, R. A., An, J., Zhou, H., Marquez, J. M., Ong‐Su, A. L., Brettler, J. W., & Reynolds, K. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf082 · Cited by 1
Chaves, P. H. M., Desoria, M., Roque, L., & Mas, R. (2025) · medRxiv · doi:10.1101/2025.05.29.25328595
“Despite the fact that efficacious intervention approaches for blood pressure (BP) control in adults with hypertension exist 4–8 , BP control rates in large populations remain disappointingly low 9–11 .”
The Impact of Smart Management Model on Blood Pressure Control Rate in Elderly Hypertensive Patients
孙, 浩. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551670
Mukhtar, M. A., Tariq, N., Mukhtar, A., Khalid, A., Mukhtar, A., & Mukhtar, R. (2025) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x381588250612061045
Alkhamees, N. H., AL-Mhanna, S. B., Grivas, G. V., Astuti, Y., Omar, N., Afolabi, H. A., Abubakar, B. D., Mohamed, K., & Batrakoulis, A. (2025) · Annals of Applied Sport Science · doi:10.61186/aassjournal.1447
“Clinical research consistently shows that reducing BP can lower cardiovascular mortality (9).”
Boczek, S., Herba, M., Kost, K., Smyła-Gruca, W., & Gruca, M. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3717
Racial and Disaggregated Ethnic Disparities of Blood Pressure Control in Community Health Centers
Boston, D., Hwang, J.-S., Lucas, J. A., Marino, M., Larson, Z., Sun, E., Giebultowicz, S., Quiñones, A. R., Crookes, D. M., Rodríguez, C., et al. (2025) · Journal of general internal medicine · doi:10.1007/s11606-025-09735-9
Ahmed, T., Monju, I. H., Akib, A. H., Khulal, R., Das, C., & Hashan, M. R. (2025) · medRxiv · doi:10.1101/2025.09.16.25335939
Verdecchia, P., Angeli, F., & Reboldi, G. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25902
Agüero, M. R., Chiquet, A. J., González, Y. V., Travieso, J. C. F., Nuñez, Y. R., Domínguez, Y. F., Pla, E. G., Castaño, S. M., Guerra, Y. P., Caballero, M. D. P., et al. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70126
“…cardiovascular risk, a large-scale analysis of randomized trials proved that just a simple SBP reduction of 5 mmHg lowered the risk of major cardiovascular events by about 10%, irrespective of previous diagnoses of cardiovascular disease and even at normal or high-normal blood pressure values [64].”
Zhang, Z., Fan, Z., & Han, L. (2025) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000775
“Our multivariable analysis confirmed TIS’s independence from traditional risk factors (adjusted hazard ratio: 1.92, P = 0.027), suggesting its unique role in risk stratification beyond traditional factors [14,15].”
InfluentialFrom Healthcare to Higher Ed: A Five-Level Framework for Fostering Academic Integrity
Kalra, J. (2025) · Ethics and integrity in educational contexts · doi:10.1007/978-3-031-98157-9_4
Optimal blood pressure (≤120/70 mmHg) as a marker for antihypertensive discontinuation
Boivin, J., Ferreira, J. P., & Girerd, N. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf675
Importance of Secondary Prevention in Coronary Heart Disease
Moșteoru, S., Kundnani, N. R., Rus, A.-A., Ilin, S., Ciocan, V., Albulescu, N., Nicula, M., Gaiţă, L., & Gaiță, D. I. (2025) · Medicina · doi:10.3390/medicina61112011
“A comprehensive meta-analysis has demonstrated that an incremental increase in systolic blood pressure is associated with a proportional rise in cardiovascular mortality, underscoring the importance of achieving optimal blood pressure control [26].”
Miranda, A. M., Onita, B. M., Hallal, P. C., & Florindo, A. A. (2025) · Journal of Physical Activity and Health · doi:10.1123/jpah.2025-0344
Arshed, M., Zakar, R., Umer, M. F., Kiran, M., Ullah, N., Iftikhar, G., & Fischer, F. (2023) · Figshare · doi:10.6084/m9.figshare.23651413
Liu, S., Li, F., Zhang, C., Wei, B., Wan, J., & Shao, H. (2023) · Figshare · doi:10.6084/m9.figshare.23733135
Hasebe, M., Yoshiji, S., Keidai, Y., Minamino, H., Murakami, T., Tanaka, D., Fujita, Y., Harada, N., Hamasaki, A., & Inagaki, N. (2024) · Figshare · doi:10.6084/m9.figshare.26575994
Adediran, E., Owens, R. E., Gardner, E., Curtin, A. D., Stuligross, J., Forbes, D., Wang, J., & Ose, D. J. (2024) · Figshare · doi:10.6084/m9.figshare.26798763
Liu, S., Li, F., Zhang, C., Wei, B., Wan, J., & Shao, H. (2023) · Figshare · doi:10.6084/m9.figshare.23733132
Gupta, R. D., Akonde, M., Sajal, I. H., & Al Kibria, G. M. (2021) · Figshare · doi:10.6084/m9.figshare.14129412
Sohn, I. S., Kim, C. J., Yoo, B.-S., Kim, B. J., Choi, J. W., Kim, D.-I., Lee, S.-H., Song, W.-H., Jeon, D. W., Cha, T. J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17210571
Gupta, R. D., Akonde, M., Sajal, I. H., & Al Kibria, G. M. (2021) · Figshare · doi:10.6084/m9.figshare.14129415
Delaney, J. A. C., Olson, N. C., Sitlani, C. M., Fohner, A. E., Huber, S. A., LANDAY, A. L., Heckbert, S. R., Tracy, R. P., Psaty, B. M., Feinstein, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13633010
Martín-Fernández, J., Alonso‐Safont, T., Polentinos-Castro, E., Esteban-Vasallo, M. D., Ariza-Cardiel, G., González-Anglada, M. I., Perruca, L. S., Rodríguez-Martínez, G., del Campo, R. R., & Bilbao-González, A. (2023) · Figshare · doi:10.6084/m9.figshare.22623391
Gupta, R. D., Akonde, M., Sajal, I. H., & Al Kibria, G. M. (2021) · Figshare · doi:10.6084/m9.figshare.14129421
Adediran, E., Owens, R. E., Gardner, E., Curtin, A. D., Stuligross, J., Forbes, D., Wang, J., & Ose, D. J. (2024) · Figshare · doi:10.6084/m9.figshare.26798766
Strumann, C., Engler, N., von Meißner, W., Blickle, P.-G., & Steinhäuser, J. (2024) · Figshare · doi:10.6084/m9.figshare.25203607
Delaney, J. A. C., Olson, N. C., Sitlani, C. M., Fohner, A. E., Huber, S. A., LANDAY, A. L., Heckbert, S. R., Tracy, R. P., Psaty, B. M., Feinstein, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13633013
Liu, S., Li, F., Zhang, C., Wei, B., Wan, J., & Shao, H. (2023) · Figshare · doi:10.6084/m9.figshare.23733141
Gupta, R. D., Akonde, M., Sajal, I. H., & Al Kibria, G. M. (2021) · Figshare · doi:10.6084/m9.figshare.14129418
Liu, S., Li, F., Zhang, C., Wei, B., Wan, J., & Shao, H. (2023) · Figshare · doi:10.6084/m9.figshare.23733138
Additional file 1 of Financial incentives for hypertension control: rationale and study design
Zheng, L., Wang, Y., Liu, S., Zheng, R., Pei, D., Sun, Y., & Sun, Z. (2020) · Figshare · doi:10.6084/m9.figshare.11966973
Delaney, J. A. C., Olson, N. C., Sitlani, C. M., Fohner, A. E., Huber, S. A., LANDAY, A. L., Heckbert, S. R., Tracy, R. P., Psaty, B. M., Feinstein, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13633007
Gupta, R. D., Akonde, M., Sajal, I. H., & Al Kibria, G. M. (2021) · Figshare · doi:10.6084/m9.figshare.14129409
Gan, L., Zhao, B., Inoue-Choi, M., Liao, L. M., Graubard, B. I., Weinstein, S. J., Albanes, D., & Huang, J. (2024) · Figshare · doi:10.6084/m9.figshare.25464873
Селезнев, С. В., Shchulkin, A. V., Yakusheva, E. N., Yakushin, S. S., Mylnikov, P. Y., Nikulina, N., Abalenikhina, Y. V., & MZHAVANADZE, N. D. (2025) · I P Pavlov Russian Medical Biological Herald · doi:10.17816/pavlovj693157
FROM CIGARETTES TO THE FUTURE: ALTERNATIVE WAYS TO ADMINISTER NICOTINE
Sikora, M., Drabik, M., Nowak, J. M., Platschek, M., Dybalska, K., Kosmulska, J., Kęska, M., Tuleja, A. B., Kolano, S. W., & Szkarłat, K. J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4252
Niakan, A., Cushman, W. C., & Kotsis, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00369-1
Yang, D., Huang, J., Duan, L., Chen, Z., & Feng, Y. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02177-2
Long-term memory effects of an incremental blood pressure intervention in a mortal cohort
Josefsson, M., Karalija, N., & Daniels, M. J. (2026) · Biometrics · doi:10.1093/biomtc/ujaf176
“That is, what we call a survivors average intervention effect : Note, previous studies have shown a the link between reduced sBP and reduced all-cause mortality (Bundy et al., 2017 ).”
Brouwers, S., Justine, H., Chabot, M., Nieuwenhuyse, B. V., Bacquer, D. D., & Daniel, M. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70230
Zhao, J., Zhang, X., Zhang, L., Wu, S., Chen, S., Zhao, L., Chen, B., & Li, W. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110956
Johnson, L. C. M., Galaviz, K. I., Ordóñez, C. E., Nyatela, A., Siedner, M. J., Heine, M., Klipstein‐Grobusch, K., Ali, M. K., Venter, F., Marconi, V. C., et al. (2026) · Translational Behavioral Medicine · doi:10.1093/tbm/ibag008
Fladerer-Grollitsch, J.-P., Bučar, F., Klein, T., Kompek, A., Menzel, D., & Schön, C. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158138
Challenges in personalized evidence-based medicine, applications in type 2 diabetes
Grenet, G. (2019) · theses.fr (ABES) · doi:10.70675/3c0d95afza6c0z4a90zb34az472f1eccb72a
Chamberlain, A. M., Cooper‐DeHoff, R. M., Fontil, V., Park, S., Shaw, K. M., Smith, M. C., Carton, T. W., O'Brien, E. C., Modrow, M. F., Wozniak, G. D., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045694
Poudel, B., Wang, Z., Shimbo, D., Schwartz, J. E., Reynolds, K., Harrison, T. N., Cannavale, K. L., Wei, R., Muntner, P., Bowling, C. B., et al. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100791
Feigin, V. L., Krishnamurthi, R., DeSilva, D., Yee, L., Dyer, J., Nair, B., Ao, B. T., Bennett, D., Arroll, B., Choy, L., et al. (2026) · medRxiv · doi:10.64898/2026.05.07.26352701
DETECTION OF DRUG-DRUG INTERACTIONS CAUSED BY ANTI-HYPERTENSIVES: AN OBSERVATIONAL STUDY
Tanırcan, B., & Arslan, M. (2026) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1766785
Circadian profile of 24-hour ambulatory blood pressure monitoring in healthy young adults
GOEL, A., Goyal, M., Mahadule, A. A., Verma, N., & Tiwari, S. (2026) · The National Medical Journal of India · doi:10.25259/nmji_617_2023
Anderson, V. A., Kambo, K., Bruce‐Low, S., Galbraith, A., O’Driscoll, J. M., & Edwards, J. J. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004320
Nutritional and Health Aspects of Oat Proteins
Hu, X., Rafique, H., & Ren, T. (2026) · doi:10.1002/9781394369522.ch08
Hu, Y., Jamal, H., Deng, X., Lawrence, K. G., Werder, E. J., Launer, L. J., & Sandler, D. P. (2026) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-026-00915-1
Che, B., Yeerken, M., Luo, K. W., Peng, W., Wei, M., Yang, X., Lu, Y.-R., Zhou, X., Wang, H., Ma, F., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1759080
“It was also indicative that progressively lower BP lower stroke risk in these patients, which corroborated previous findings in a network meta-analysis of the relationship between SBP and stroke risk among hypertensive subjects (22).”
Zoysa, P. D., Weerarathna, T., Darshana, I., Egodage, U., Rathnayake, R., Jayasekara, M. M. P. T., Sujanitha, V., Matthias, A., Ratnayake, B., Mayurathan, P., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06062-7
“Evidence from multiple studies indicates a consistent, linear relationship between achieved systolic blood pressure (SBP) and the risk of cardiovascular events and death [4].”
Hypertension management: is lower always better?
Shamsulddin, A. B. (2026) · Minerva Medica · doi:10.23736/s0026-4806.26.09891-5
Yu, D., Yu, Y., Zhang, T., Huang, W., Liang, X., & Ruan, Z. (2026) · International Journal of Clinical Practice · doi:10.1155/ijcp/6665417
Masrouri, S., Trainor, P. J., Chevli, P. A., Lima, J. A. C., Tsimikas, S., DeFilippis, A. P., & Shapiro, M. D. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047698
Mian, M. H. S., Janahi, K. A. H. A., Tayeb, A., Musaffar, F. M. M., Khalil, N., Toubah, S. H. A., Karim, A. M. A., Almarzooqi, A. M., Sayfoo, F. M., Hamadeh, A., et al. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01888-y
Tang, B., & Gu, W. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1711504
“A recent study by (18) further strengthened the evidence base, demonstrating that intensive systolic BP lowering consistently reduced cardiovascular events across multiple populations, with relative risk reductions ranging from 20% to 25%.”
Huang, A. L., & Vongpatanasin, W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00059-7
Guimarães, M. C. D. L. P., Coelho, J. C., dos Santos, J., Meira, K. C., Vattimo, M. D. F. F., Costa, E., da Silva, G. V., Drager, L. F., & Pierin, Â. M. G. (2026) · Clinical Hypertension · doi:10.5646/ch.2026.32.e37
Yu, Q., Tian, Y., Shen, S., Yan, Y., Liu, X., & Liu, Z. (2026) · Archives of Iranian Medicine · doi:10.34172/aim.34957
Li, F., Li, M., Guo, S., Cao, Y., Zhang, Q., Cheng, T., & Li, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1743254
“A review found that each 10 mmHg decrease in SBP (mean SBP of 120–124 mmHg) was associated with a 29 % reduction in cardiovascular disease and 27 % reduction in all-cause mortality compared with a mean SBP of 130–134 mmHg (20).”
Chaves, P. H. M., Desoria, M., Roque, L., & Mas, R. J. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70297
Association of urinary sodium and potassium excretion with outcomes of neuroendocrine cancer
Sun, Q., Aji, M., Yan, X., Zhang, Y., Nan, F., Wang, Y., & Li, L. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1866503
“Prior research has linked elevated STP ratios to hypertension and cardiovascular mortality (10, 19, 20), suggesting that it may also serve as a prognostic marker in cancer patients with renal metabolic disturbances.”
Etayo-Urtasun, P., de Asteasu, M. L. S., & Izquierdo, M. (2026) · Hypertension Research · doi:10.1038/s41440-026-02784-5
Rapti, I., Markozannes, G., Papathanasiou, O. E., Veroni, A., Zachariades, C., Tseretopoulou, X., Kotanidou, E. P., Serbis, A., Koutras, V., Rizos, E. C., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1749319
“As long as elevated SBP is a risk factor for cardiovascular disease, a decrease of SBP during childhood and adolescence could also lead to a reduction of cardiovascular risk during adulthood (65).”
Sun, G., Guo, X., Zhao, C., Ouyang, N., Li, G., Wang, C., Ren, Y., Xing, L., Sun, Z., Qiao, L., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.082511
Self-citationAchieved systolic blood pressure and cardiovascular outcomes in advanced chronic kidney disease
Al‐Sodany, E., Szummer, K. E., Österman, J., Dietrich, C. E., Carrero, J. J., Heimbürger, O., Barany, P. F., & Evans, M. (2026) · Clinical Kidney Journal · doi:10.1093/ckj/sfag296
“BP values were obtained as attended clinic readings rather than with SPRINT’s largely unattended protocol, which has been difficult to compare with other trials [ 3 8 ].”
InfluentialLee, J. J., Zunti, J., Song, G., Low, R., Zhang, J. J., Pollock, J., & Koro, M. (2026) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.3138/cpj-26-0006
Chambari, M., Mardani, H., Roshandel, M., Rafiei, H., Linsenmeyer, W. R., Jafari, M., Ulaganathan, V., & Jafari, A. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72357
“While the absolute change in SBP may appear modest at the individual level, even small reductions in SBP have been shown to yield meaningful reductions in cardio-vascular morbidity and mortality across populations (Bundy et al. 2017).”
Yang, H., Li, Y., Xiang, G., Pei, S., Wang, M., Xu, L., Zhu, B., Liu, Y., & Yang, X. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1929546
“Despite decades of evidence demonstrating that antihypertensive therapy effectively reduces cardiovascular risk (30, 31), the optimal blood pressure treatment target remains a subject of significant debate.”
Ulbasheva, Z. (2026) · Saratov Journal of Medical Scientific Research · doi:10.15275/ssmj2201084
Pisaruk, A. (2026) · Problems of ageing and longevity (Ukraine) · doi:10.71012/pro-ageing-2026-3-08
Baker, W. L. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag077
Triệt đốt thần kinh giao cảm thận: Triển vọng mới từ những dữ liệu gần đây
Hiếu, T. B., Quang, N. N., Phong, P. Đ., & Hùng, P. M. (2026) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.103.2022.1373
Jowf, G. I. A., & Ahmed, W. (2026) · Healthcare · doi:10.3390/healthcare14203538
“High blood pressure is a leading risk factor for coronary heart disease, heart failure, and stroke [17–19].”
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Metadata
- Authors
- Bundy, J. D., Li, C., Stuchlik, P., Bu, X., Kelly, T. N., Mills, K. T., He, H., Chen, J., Whelton, P. K., & He, J.
- Affiliations
- Tulane University (US)
- Corresponding author
- He, Jiang
- ORCID
- Venue
- JAMA Cardiology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-07-01
- Volume
- 2
- Issue
- 7
- Pages
- 775
- ISSN
- 2380-6583 (ISSN-L)
- PMC
- PMC5710614
- OpenAlex
- W2618382346
- Cited by
- 783
- References
- 33
- Citations by year
- 2026: 59 · 2025: 102 · 2024: 96 · 2023: 99 · 2022: 65 · 2021: 95 · 2020: 80 · 2019: 78 · 2018: 73 · 2017: 35
- FWCI
- 56.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Cardiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM109036)
- Fogarty International Center (D43TW009107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- systolic blood pressure, blood pressure targets, hypertension, antihypertensive therapy, cardiovascular disease, all-cause mortality, blood pressure reduction, linear dose-response relationship, cardiovascular risk reduction, cardiovascular disease prevention, cardiovascular disease prevention and treatment
- MeSH terms
- Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Humans, Hypertension, Mortality, Patient Care Planning, Systole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review